Asian Spectator

Times Advertising

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Brea...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
SCHAFFHAUSEN, Switzerland, Jan. 19, 2021 /PRNewswire-AsiaNet/ -- Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) p...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Bahaya bertanya ke AI: Separuh jawaban kesehatan menyesatkan, meski terdengar meyakinkan

Ilustrasi AI.Who is Danny/Shutterstock.comBayangkan kamu baru saja didiagnosis kanker stadium awal. Sebelum janji temu berikutnya dengan dokter, kamu bertanya ke chatbot berbasis kecerdasan buatan (AI...

Why Contractors Suction Hose Solutions Are Essential For Heavy-Duty Fluid Handling

In industries where materials move as relentlessly as time itself, equipment must match that intensity. Whether on construction sites, agricultural operations, or large-scale industrial setups, flui...

Skenario terburuk El Niño 2026: Puncak ‘neraka’ panas yang mengancam

Tahun ini Indonesia diprediksi bakal menghadapi musim kemarau yang tidak biasa. Bukan hanya sekadar panas, musim kemarau juga diperkirakan akan datang lebih cepat, lebih kering, dan masanya lebih lama...